TITLE

The strange world inside Canada's only level-4 containment laboratory

AUTHOR(S)
Square, David
PUB. DATE
November 1999
SOURCE
CMAJ: Canadian Medical Association Journal;11/02/99, Vol. 161 Issue 9, p1171
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Reports on the Canadian Science Centre for Human and Animal Health in Winnipeg, Manitoba. Security at the level-4 containment laboratory; Formation of the Bureau of Microbiology, a national reference facility for culture collections, within the Laboratory Centre for Disease Control; Research on the Marburg virus. INSET: Different levels of concern..
ACCESSION #
2442976

 

Related Articles

  • Marburg Vaccine Shows Promise. Hampton, Tracy // JAMA: Journal of the American Medical Association;5/24/2006, Vol. 295 Issue 20, p2346 

    The article reports on a vaccine that can prevent hemorrhagic fever in monkeys after they have been exposed to Marburg virus. Scientists at the U.S. Army Medical Research Institute of Infectious Diseases scientist, led by Thomas Geisbert, and colleagues at the National Microbiology Laboratory at...

  • Response to Imported Case of Marburg Hemorrhagic Fever, the Netherlands. Timen, Aura; Koopmans, Marion P. G.; Vossen, Ann C. T. M.; van Doornum, Gerard J. J.; Günther, Stephan; Van den Berkmortel, Franchette; Verduin, Kees M.; Dittrich, Sabine; Emmerich, Petra; Osterhaus, Albert D. M. E.; van Dissel, Jaap T.; Coutinho, Roel A. // Emerging Infectious Diseases;Aug2009, Vol. 15 Issue 8, p1171 

    On July 10, 2008, Marburg hemorrhagic fever was confirmed in a Dutch patient who had vacationed recently in Uganda. Exposure most likely occurred in the Python Cave (Maramagambo Forest), which harbors bat species that elsewhere in Africa have been found positive for Marburg virus. A...

  • Postexposure Treatment of Marburg Virus Infection. Geisbert, Thomas W.; Hensley, Lisa E.; Geisbert, Joan B.; Leung, Anders; Johnson, Joshua C.; Grolla, Allen; Feldmann, Heinz // Emerging Infectious Diseases;Jul2010, Vol. 16 Issue 7, p1119 

    Rhesus monkeys are protected from disease when a recombinant vesicular stomatitis virus-based vaccine is administered 20-30 min after infection with Marburg virus. We protected 5/6 monkeys when this vaccine was given 24 h after challenge; 2/6 animals were protected when the vaccine was...

  • Marburg haemorrhagic fever, Angola - update.  // Weekly Epidemiological Record;5/20/2005, Vol. 80 Issue 20, p178 

    This article focuses on an update of Marburg haemorrhagic fever in Angola. As of 17 May 2005, the Ministry of Health in Angola has reported 337 cases of Marburg haemorrhagic fever. Of these cases, 311 were fatal. Infrastructures and protocols for controlling the outbreak are in place and...

  • A Review of Filovirus Work and Facilities at The Defence Science and Technology Laboratory Porton Down. Smither, Sophie J.; Lever, Mark S. // Viruses (1999-4915);Aug2012, Vol. 4 Issue 8, p1305 

    Porton Down houses two separate sites capable of conducting high containment research on ACDP (Advisory Committee on Dangerous Pathogens) Hazard Group 4 agents: the Defence Science and Technology Laboratory (Dstl) and the Health Protection Agency (HPA), and filovirus research has been performed...

  • Potential Marburg and Ebola vaccines.  // MLO: Medical Laboratory Observer;Jul2005, Vol. 37 Issue 7, p8 

    Reports on the development of Marburg and Ebola vaccines by a team of scientists from the Public Health Agency of Canada in Winnipeg, Manitoba and the U.S. Army Medical Research Institute of Infectious Diseases in Fort Detrick, Maryland that prevented macaque monkeys from contracting the viruses...

  • Diagnostic Reverse-Transcription Polymerase Chain Reaction Kit for Filoviruses Based on the Strain Collections of all European Biosafety Level 4 Laboratories. Panning, Marcus; Laue, Thomas; Ölschlager, Stephan; Eickmann, Markus; Becker, Stephan; Raith, Sabine; Courbot, Marie-Claude Georges; Nilsson, Mikael; Gopal, Robin; Lundkvist, Ake; di Caro, Antonino; Brown, David; Meyer, Hermann; Lloyd, Graham; Kümmerer, Beate M.; Günther, Stephan; Drosten, Christian // Journal of Infectious Diseases;11/15/2007 Supplement, Vol. 196 Issue 2, pS199 

    A network of European biosafety level 4 laboratories has designed the first industry-standard molecular assay for all filoviruses species, based on the strain collections of all participants. It uses 5 optimized L gene primers and 3 probes, as well as an internal control with a separate...

  • Emergency Marburg treatment succeeds in test.  // New Scientist;5/6/2006, Vol. 190 Issue 2550, p21 

    This article reports that a vaccine has been tested that could prevent the deadly Marburg virus from causing disease. The virus, like its cousin Ebola, causes a haemorrhagic disease. Though outbreaks are rare, combating Marburg virus is a high priority, partly because each outbreak gives it...

  • The Baboon (Papio spp.) as a Model of Human Ebola Virus Infection. Perry, Donna L.; Bollinger, Laura; White, Gary L. // Viruses (1999-4915);Oct2012, Vol. 4 Issue 10, p2400 

    Baboons are susceptible to natural Ebola virus (EBOV) infection and share 96% genetic homology with humans. Despite these characteristics, baboons have rarely been utilized as experimental models of human EBOV infection to evaluate the efficacy of prophylactics and therapeutics in the United...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics